相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Allosteric Modulator ORG27569 Induces CB1 Cannabinoid Receptor High Affinity Agonist Binding State, Receptor Internalization, and Gi Protein-independent ERK1/2 Kinase Activation
Kwang H. Ahn et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Psychopharmacology of the endocannabinoids: far beyond anandamide
F. A. Pamplona et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2012)
Role of CB1 cannabinoid receptors on GABAergic neurons in brain aging
Onder Albayram et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Endocannabinoid Hydrolysis Generates Brain Prostaglandins That Promote Neuroinflammation
Daniel K. Nomura et al.
SCIENCE (2011)
The Endocannabinoid 2-Arachidonoylglycerol Produced by Diacylglycerol Lipase α Mediates Retrograde Suppression of Synaptic Transmission
Asami Tanimura et al.
NEURON (2010)
Aspirin-triggered lipoxin induces CB1-dependent catalepsy in mice
Fabricio A. Pamplona et al.
NEUROSCIENCE LETTERS (2010)
Ajulemic acid, a synthetic cannabinoid, increases formation of the endogenous proresolving and anti-inflammatory eicosanoid, lipoxin A4
Robert B. Zurier et al.
FASEB JOURNAL (2009)
'7TM Receptor Allostery: Putting Numbers to Shapeshifting Proteins
Terry P. Kenakin
TRENDS IN PHARMACOLOGICAL SCIENCES (2009)
Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum
Mauro Maccarrone et al.
NATURE NEUROSCIENCE (2008)
Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators
Charles N. Serhan et al.
NATURE REVIEWS IMMUNOLOGY (2008)
PSNCBAM-1, a novel allosteric antagonist at cannabinoid CB1 receptors with hypophagic effects in rats
J. G. Horswill et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Functional selectivity through protean and biased agonism: Who steers the ship?
Terry Kenakin
MOLECULAR PHARMACOLOGY (2007)
The fatty acid amide hydrolase inhibitor URB597 (cyclohexylcarbamic acid 3′-carbamoylbiphenyl-3-yl ester) reduces neuropathic pain after oral administration in mice
Roberto Russo et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Endocannabinoids and β-amyloid-induced neurotoxicity in vivo:: effect of pharmacological elevation of endocannabinoid levels
M. van der Stelt et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2006)
AM251, a selective antagonist of the CB1 receptor, inhibits the induction of long-term potentiation and induces retrograde amnesia in rats
LD Alvares et al.
BRAIN RESEARCH (2006)
The endocannabinoid system as an emerging target of pharmacotherapy
Pal Pacher et al.
PHARMACOLOGICAL REVIEWS (2006)
The cannabinoid agonist WIN55,212-2 increases intracellular calcium via CB1 receptor coupling to Gq/11 G proteins
JE Lauckner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Allosteric modulation of the cannabinoid CB1 receptor
MR Price et al.
MOLECULAR PHARMACOLOGY (2005)
Selective inhibition of 2-AG hydrolysis enhances endocannabinoid signaling in hippocampus
JK Makara et al.
NATURE NEUROSCIENCE (2005)
Host control of Mycobacterium tuberculosis is regulated by 5-lipoxygenase-dependent lipoxin production
A Bafica et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Prevention of Alzheimer's disease pathology by cannabinoids:: Neuroprotection mediated by blockade of microglial activation
BG Ramírez et al.
JOURNAL OF NEUROSCIENCE (2005)
CB1 cannabinoid receptors and on-demand defense against excitotoxicity
G Marsicano et al.
SCIENCE (2003)
A novel rat lipoxin A4 receptor that is conserved in structure and function
N Chiang et al.
BRITISH JOURNAL OF PHARMACOLOGY (2003)
Principles:: Extending the utility of [35S]GTPγS binding assays
G Milligan
TRENDS IN PHARMACOLOGICAL SCIENCES (2003)
The molecular logic of endocannabinoid signalling
D Piomelli
NATURE REVIEWS NEUROSCIENCE (2003)
International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. XXXVIII. Update on terms and symbols in quantitative pharmacology
RR Neubig et al.
PHARMACOLOGICAL REVIEWS (2003)
Pharmacophores for ligand recognition and activation/inactivation of the cannabinoid receptors
PH Reggio
CURRENT PHARMACEUTICAL DESIGN (2003)
Parasite-induced lipoxin A4 is an endogenous regulator of IL-12 production and immunopathology in Toxoplasma gondii infection
J Aliberti et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Oxygenated metabolites of anandamide and 2-arachidonoylglycerol:: Conformational analysis and interaction with cannabinoid receptors, membrane transporter, and fatty acid amide hydrolase
M van der Stelt et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
International Union of Pharmacology. XXVII. Classification of cannabinoid receptors
AC Howlett et al.
PHARMACOLOGICAL REVIEWS (2002)
G protein-coupled receptor allosterism and complexing
A Christopoulos et al.
PHARMACOLOGICAL REVIEWS (2002)
Oxidative metabolism of endocannabinoids
KR Kozak et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2002)
Despite substantial degradation, 2-arachidonoylglycerol is a potent full efficacy agonist mediating CB1 receptor-dependent G-protein activation in rat cerebellar membranes
JR Savinainen et al.
BRITISH JOURNAL OF PHARMACOLOGY (2001)
A possible role of lipoxygenase in the activation of vanilloid receptors by anandamide in the guinea-pig bronchus
SJ Craib et al.
BRITISH JOURNAL OF PHARMACOLOGY (2001)
Lipoxins: revelations on resolution
B McMahon et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2001)
分享论文
